Evofem Biosciences, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Evofem Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evofem Biosciences, Inc. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2020 | NEOT | Evofem Biosciences ... | Rarick Lisa Dale | Director | Option Exercise | A | 5.85 | 75,000 | 438,750 | 75,000 | |
| Feb 21 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Sell | S | 7.00 | 1,000 | 7,000 | 196,226 | 197.2 K to 196.2 K (-0.51 %) |
| Feb 21 2020 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Sell | S | 6.50 | 14,957 | 97,221 | 332,240 | 347.2 K to 332.2 K (-4.31 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Grant | A | 0.00 | 150,000 | 0 | 347,197 | 197.2 K to 347.2 K (+76.07 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Grant | A | 5.21 | 899 | 4,684 | 197,197 | 196.3 K to 197.2 K (+0.46 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 4.87 | 300,000 | 1,461,000 | 300,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 0.00 | 300,000 | 0 | 666,135 | 366.1 K to 666.1 K (+81.94 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 5.21 | 3,846 | 20,038 | 366,135 | 362.3 K to 366.1 K (+1.06 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Grant | A | 0.00 | 150,000 | 0 | 213,331 | 63.3 K to 213.3 K (+236.85 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 150,000 | 0 | 331,097 | 181.1 K to 331.1 K (+82.83 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 5.21 | 3,846 | 20,038 | 181,097 | 177.3 K to 181.1 K (+2.17 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 0.00 | 150,000 | 0 | 197,226 | 47.2 K to 197.2 K (+317.62 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 5.21 | 3,688 | 19,214 | 47,226 | 43.5 K to 47.2 K (+8.47 %) |